Serum müllerian-inhibiting substance levels in adolescent girls with normal menstrual cycles or with polycystic ovary syndrome
- 31 October 2005
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 84 (4) , 938-944
- https://doi.org/10.1016/j.fertnstert.2005.02.052
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metforminFertility and Sterility, 2004
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndromePublished by Elsevier ,2004
- Adult polycystic ovary syndrome begins in childhoodBest Practice & Research Clinical Endocrinology & Metabolism, 2002
- Antimüllerian hormone serum levels: a putative marker for ovarian agingFertility and Sterility, 2002
- Serum müllerian-inhibiting substance levels during normal menstrual cyclesFertility and Sterility, 2000
- Polycystic ovaries and associated clinical and biochemical features in young womenClinical Endocrinology, 1999
- The role of anti-Müllerian hormone in gonadal developmentMolecular and Cellular Endocrinology, 1998
- Measurement of total serum testosterone levels using commercially available kits: high degree of between-kit variabilityFertility and Sterility, 1998
- Müllerian inhibiting substance as oocyte meiosis inhibitorMolecular and Cellular Endocrinology, 1986
- Plasma free testosterone in the diagnosis of adolescent polycystic ovary syndromeThe Journal of Pediatrics, 1983